Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Jiandong Zhao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7868-1051; OpenAlex author ID A5046299288. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 3

  1. Quantification of GPC1(+) Exosomes Based on MALDI-TOF MS In Situ Signal Amplification for Pancreatic Cancer Discrimination and Evaluation. Co-author DOI 10.1021/acs.analchem.3c00193↗
  2. Definitive chemoradiotherapy and salvage chemotherapy for patients with isolated locoregional recurrence after radical resection of primary pancreatic cancer. Last author DOI 10.2147/cmar.s202543↗
  3. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Co-author DOI 10.1016/j.diabres.2014.04.007↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shaohan Yan · 1 shared paper, 2023 · strength 0.24
  2. Xiangmin Zhang · 1 shared paper, 2023 · strength 0.24
  3. Jiang Long · 1 shared paper, 2019 · strength 0.11
  4. Wei Shi · 1 shared paper, 2019 · strength 0.11
  5. Zheng Wang · 1 shared paper, 2014 · strength 0.04
  6. Guoliang Jiang · 1 shared paper, 2014 · strength 0.04
  7. Zhigang Ren · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.